Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Infusion vs Lidocaine Patches for Post-Cesarean Pain in OUD
NCT04033562Phase 4Terminated
- Sponsor
- WellSpan Health
- Start
- Jan 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in pain, sponsored by WellSpan Health. Started Jan 2020; status: terminated.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04033562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04033562.